Statins Safely Reduce Heart Attack and Stroke Risk in Healthy Over-70s

The landmark research shows that statin therapy provides a meaningful preventive benefit for older adults who have no prior history of cardiovascular disease.

Findings From the STAREE Trial

She noted that having solid evidence for a safe and effective prevention method offers real reassurance to older Australians and their families. The trial positions Australia at the forefront of global healthy ageing research, with Professor Zoungas highlighting that answering fundamental questions about longevity is a universal priority as the global population ages. Professor Derek Chew, Chief Scientific and Medical Officer at the National Heart Foundation of Australia, which helped fund the study, welcomed the results. He observed that while statins have reduced cardiovascular events for decades, this new research demonstrates they still make a meaningful difference when initiated much later in life.

Community-Based Design and GP Implementation

The trial involved more than 3,400 general practitioners across Australia, giving the research particular weight in everyday clinical settings. Co-author Professor Mark Nelson, a practising GP and adjunct professor at Monash’s School of Public Health and Preventive Medicine, explained that the community-based design means older patients now have a solid basis to discuss statins with their doctors. He suggested that patients can raise the topic directly at their next appointment to evaluate whether statin therapy fits into their individual cardiovascular health plan.

Professor Zoungas expressed hope that the findings will prompt updates to clinical treatment guidelines so doctors can properly apply the evidence in practice. The trial was structured specifically to serve as a benchmark for international clinical research capable of directly informing preventive care worldwide.